| Dr Ami Amar Shah Vira, MD | |
|
210 N Lakeline Blvd Ste 100, Cedar Park, TX 78613-2088 | |
| (512) 553-9545 | |
| Not Available |
| Full Name | Dr Ami Amar Shah Vira |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 15 Years |
| Location | 210 N Lakeline Blvd Ste 100, Cedar Park, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801023049 | NPI | - | NPPES |
| 83050379 | Other | TX | TAX ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0200X | Ophthalmology - Ophthalmic Plastic And Reconstructive Surgery | Q3461 (Texas) | Secondary |
| 207W00000X | Ophthalmology | Q3461 (Texas) | Primary |
| Entity Name | Clarity Eye Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417125311 PECOS PAC ID: 0648343616 Enrollment ID: O20080724000079 |
News Archive
The American Society for Radiation Oncology (ASTRO) has released evidence-based guidelines to define appropriate fractionation of whole breast irradiation (WBI), finding that hypofractionated (HF) WBI is effective for many patients with early-stage breast cancer. These guidelines are published in the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO.
Arena Pharmaceuticals, Inc. announced today a reduction of its US workforce of approximately 25%, or 66 employees. As a result of the workforce reduction, which Arena plans to complete around March 28, 2011, the company expects to incur restructuring charges, primarily in the first quarter of 2011, of approximately $3.8 million in connection with one-time employee termination costs.
New research published on the preprint server bioRxiv* suggests S2-specific antibody responses are critical in recovering from mild to severe COVID-19 infection. Compared to patients who died within 28 days of their COVID-19 diagnosis, patients who produced a wide range of S2-specific responses were more likely to survive.
A substantial number of premature infants born before 27 weeks gestational age encounter complicated medical problems. Although the survival rate of these infants has increased over the last two decades, the survival data for these patients is highly variable.
MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.
› Verified 4 days ago
| Entity Name | Oliver Street 5.01(a) Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457695413 PECOS PAC ID: 0042464125 Enrollment ID: O20130128000189 |
News Archive
The American Society for Radiation Oncology (ASTRO) has released evidence-based guidelines to define appropriate fractionation of whole breast irradiation (WBI), finding that hypofractionated (HF) WBI is effective for many patients with early-stage breast cancer. These guidelines are published in the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO.
Arena Pharmaceuticals, Inc. announced today a reduction of its US workforce of approximately 25%, or 66 employees. As a result of the workforce reduction, which Arena plans to complete around March 28, 2011, the company expects to incur restructuring charges, primarily in the first quarter of 2011, of approximately $3.8 million in connection with one-time employee termination costs.
New research published on the preprint server bioRxiv* suggests S2-specific antibody responses are critical in recovering from mild to severe COVID-19 infection. Compared to patients who died within 28 days of their COVID-19 diagnosis, patients who produced a wide range of S2-specific responses were more likely to survive.
A substantial number of premature infants born before 27 weeks gestational age encounter complicated medical problems. Although the survival rate of these infants has increased over the last two decades, the survival data for these patients is highly variable.
MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.
› Verified 4 days ago
| Entity Name | Ami Shah Vira Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467147793 PECOS PAC ID: 8628433398 Enrollment ID: O20230502001995 |
News Archive
The American Society for Radiation Oncology (ASTRO) has released evidence-based guidelines to define appropriate fractionation of whole breast irradiation (WBI), finding that hypofractionated (HF) WBI is effective for many patients with early-stage breast cancer. These guidelines are published in the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO.
Arena Pharmaceuticals, Inc. announced today a reduction of its US workforce of approximately 25%, or 66 employees. As a result of the workforce reduction, which Arena plans to complete around March 28, 2011, the company expects to incur restructuring charges, primarily in the first quarter of 2011, of approximately $3.8 million in connection with one-time employee termination costs.
New research published on the preprint server bioRxiv* suggests S2-specific antibody responses are critical in recovering from mild to severe COVID-19 infection. Compared to patients who died within 28 days of their COVID-19 diagnosis, patients who produced a wide range of S2-specific responses were more likely to survive.
A substantial number of premature infants born before 27 weeks gestational age encounter complicated medical problems. Although the survival rate of these infants has increased over the last two decades, the survival data for these patients is highly variable.
MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ami Amar Shah Vira, MD 10012 Lavon Bnd, Austin, TX 78717-4169 Ph: (512) 553-9545 | Dr Ami Amar Shah Vira, MD 210 N Lakeline Blvd Ste 100, Cedar Park, TX 78613-2088 Ph: (512) 553-9545 |
News Archive
The American Society for Radiation Oncology (ASTRO) has released evidence-based guidelines to define appropriate fractionation of whole breast irradiation (WBI), finding that hypofractionated (HF) WBI is effective for many patients with early-stage breast cancer. These guidelines are published in the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO.
Arena Pharmaceuticals, Inc. announced today a reduction of its US workforce of approximately 25%, or 66 employees. As a result of the workforce reduction, which Arena plans to complete around March 28, 2011, the company expects to incur restructuring charges, primarily in the first quarter of 2011, of approximately $3.8 million in connection with one-time employee termination costs.
New research published on the preprint server bioRxiv* suggests S2-specific antibody responses are critical in recovering from mild to severe COVID-19 infection. Compared to patients who died within 28 days of their COVID-19 diagnosis, patients who produced a wide range of S2-specific responses were more likely to survive.
A substantial number of premature infants born before 27 weeks gestational age encounter complicated medical problems. Although the survival rate of these infants has increased over the last two decades, the survival data for these patients is highly variable.
MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.
› Verified 4 days ago
John William Branch, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1130 Cottonwood Creek Trl Ste D4, Cedar Park, TX 78613 Phone: 512-551-5500 Fax: 512-551-5509 | |
Todd Robert Shepler, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 11901 W Parmer Ln, 400, Cedar Park, TX 78613 Phone: 512-528-1144 Fax: 512-528-1143 | |
Amy Neuhoff Robertson, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 12171 W Parmer Ln, Ste 201, Cedar Park, TX 78613 Phone: 512-528-1144 Fax: 512-528-1143 | |
Ms. Pooja Godara, M.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 925 Starwood Dr., Cedar Park, TX 78613 Phone: 512-327-7000 Fax: 512-259-3802 | |
Dr. Vincent Anthony Restivo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 12171 W Parmer Ln, Suite 201, Cedar Park, TX 78613 Phone: 512-528-1144 Fax: 512-528-1143 | |
Dr. Chaitanya Indukuri, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 13625 Ronald Reagan Blvd, Bldg 9, Ste 100, Cedar Park, TX 78613 Phone: 512-856-5645 |